Soleno Therapeutics's Vykat XR is the first drug to be approved for treating the insatiable hunger caused by Prader-Willi Syndrome.
Ongoing armed conflict in Ukraine and Iran, Dimon wrote, have him concerned about an economic “skunk at the party.” ...
The company filed Monday for the iShares Nasdaq 100 ETF, a result of the exchange broadening its US licensing for the index.
Saudi Arabia’s Public Investment Fund, the Qatar Investment Authority, and Abu Dhabi’s L’imad Holding Co are all aboard, per the WSJ.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results